State of Wisconsin Investment Board
SCLN

State of Wisconsin Investment Board’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

State of Wisconsin Investment Board’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-308,200
Closed -$3.45M – 1487
2017
Q3 		$3.45M Buy
308,200
+115,200
+60% +$1.27M 0.01% 911
2017
Q2 		$2.12M Buy
+193,000
New +$1.93M 0.01% 941

State of Wisconsin Investment Board's SCLN Position: Q4 2017 in Review

State of Wisconsin Investment Board sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 308,200 shares — an estimated $3.45M sold.

State of Wisconsin Investment Board first reported a position in SCLN in Q2 2017 and held it in 2 quarters. The position peaked at $3.45M in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • State of Wisconsin Investment Board reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 308,200 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $3.45M.
  • State of Wisconsin Investment Board first reported a position in Sciclone Pharmaceuticals Inc in Q2 2017 and held it in 2 quarters.
  • State of Wisconsin Investment Board's Sciclone Pharmaceuticals Inc position peaked at $3.45M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2017, filed 8 Feb 2018.